J7401 HCPCS Level II code: Mometasone furoate sinus implant, 10 micrograms
CMS terminated J7401: its last date of service was Mar 31, 2021. It stays here for looking up older claims; newer services need a current code.
Official description
J7401Mometasone furoate sinus implant, 10 micrograms
Short description: Mometasone furoate sinus imp
HCPCS · United States
Medicare details
The indicators CMS publishes with J7401 in its October 2026 file. They describe Medicare’s handling, not another payer’s.
- Medicare coverage
- Carrier judgment
- Medicare pricing
- Drugs
- Type of service
- Medical care
- BETOS category
- Other drugs
- Added
- Oct 1, 2019
- Terminated after
- Mar 31, 2021
Where J7401 sits
- 1J codesDrugs administered other than orally
- 2Terminated J7401Mometasone furoate sinus implant, 10 micrograms
Source and release
- Data release
- HCPCS Level II · October 2026
- Effective date
- Oct 1, 2026
- Publisher
- CMS
This page is built from the HCPCS Level II catalog that Vero Codes reads when it suggests codes: Centers for Medicare & Medicaid Services’s October 2026 release, imported from the publisher’s file and checked against it. The description, notes and structured data come from the same record.
Frequently asked questions
Is HCPCS code J7401 still valid?
No. CMS terminated J7401; its last date of service was Mar 31, 2021. It is listed for looking up services from before then. Use a current code for newer services.
Does Medicare cover J7401?
CMS lists J7401’s Medicare coverage as “Carrier judgment” and its pricing as “Drugs”. Coverage and payment still depend on the patient, the setting, the documentation and the payer.
Which HCPCS Level II release does this page use?
It uses CMS’s October 2026 release, in effect from Oct 1, 2026 to Dec 31, 2026. It is a reference: confirm the code against the current list and the payer’s rules before you submit it.
Codes beside J7401
All J codesJ7351Injection, bimatoprost, intracameral implant, 1 microgramJ7352Afamelanotide implant, 1 mgJ7353Anacaulase-bcdb, 8.8% gel, 1 gramJ7354Cantharidin for topical administration, 0.7%, single unit dose applicator (3.2 mg)J7355Injection, travoprost, intracameral implant, 1 microgramJ7356Injection, foscarbidopa 0.25 mg/foslevodopa 5 mgJ7402Mometasone furoate sinus implant, (sinuva), 10 microgramsJ7500Azathioprine, oral, 50 mgJ7501Azathioprine, parenteral, 100 mgJ7502Cyclosporine, oral, 100 mgJ7503Tacrolimus, extended release, (envarsus xr), oral, 0.25 mgJ7504Lymphocyte immune globulin, antithymocyte globulin, equine, parenteral, 250 mg